Skip to content

Verification of Prediction Algorithm

Verification of a Prediction Algorithm for Cardiopulmonary Patients Admitted to the Emergency Department (ED) (VPAC)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02863666
Acronym
VPAC
Enrollment
673
Registered
2016-08-11
Start date
2016-08-11
Completion date
2017-12-15
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradycardia, Difficulty Breathing, Shortness of Breath Episode, Tachycardia

Keywords

Cariopulmonary, cardiac arrest

Brief summary

Prospective observational clinical study to verify an algorithm used to predict cardiopulmonary events in patients presenting to the emergency department.

Detailed description

A novel algorithm for determining risk of acute cardiac complications, including cardiac arrest, for patients presenting to the ED has recently been reported. Unlike prior risk stratification tools that relied on basic vital sign data, this algorithm utilizes advanced computing of ECG data to solve the risk classification problem. Data will be collected on patients presenting to the emergency department with a primary complaint that is determined to be cardiopulmonary of origin by a clinician. Verification of the results of the previous studies using this algorithm in a more diverse patient cohorts is required. As such, the proposed study will investigate the accuracy of the algorithm.

Interventions

None listed

Sponsors

Zoll Medical Corporation
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

18 years of age or older Admission to emergency department requiring immediate medical attention due to presumed cardiac or pulmonary cause(s) and considered 2nd or 3rd tier priority in triage system.

Exclusion criteria

Pregnant or suspected pregnancy Significant trauma Do Not Resuscitate order Known as Ward of the State

Design outcomes

Primary

MeasureTime frameDescription
Number of Subjects With a Cardiopulmonary EventWithin 72 hours of presentation to EDThe number of any cardiopulmonary event, not limited to: Cardiac arrest Sustained ventricular tachycardia (VT) Hypotension requiring inotropes or intra-aortic balloon pump (IABP) insertion Intubation or mechanical ventilation Complete heart block Bradycardia requiring insertion of a pacing wire or external pacing, and Percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG)

Secondary

MeasureTime frameDescription
Cumulative Number of Cardiopulmonary Events in a Single SubjectWithin 72 hours of presentation to EDThe cumulative number of any cardiac and cardiac-related events, not limited to: In-hospital Death In-hospital Cardiac Arrest Composite cardiovascular outcome or intervention (Lethal Arrhythmias , Acute Pulmonary Edema, Cardiogenic Shock, Myocardial Infarction, Percutaneous Coronary Intervention, Coronary artery Bypass Surgery , New or Recurrent MI, Recurrent Ischemia requiring Revascularization)

Countries

Belgium, United States

Participant flow

Participants by arm

ArmCount
Enrolled
Enrolled subjects in observational study
673
Total673

Baseline characteristics

CharacteristicEnrolled
Age, Continuous58.8 years
STANDARD_DEVIATION 14.95
Ethnicity (NIH/OMB)
Hispanic or Latino
8 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
665 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
6 Participants
Race (NIH/OMB)
Black or African American
167 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
29 Participants
Race (NIH/OMB)
White
471 Participants
Region of Enrollment
Belgium
253 participants
Region of Enrollment
United States
420 participants
Sex: Female, Male
Female
304 Participants
Sex: Female, Male
Male
369 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 673
other
Total, other adverse events
5 / 673
serious
Total, serious adverse events
0 / 673

Outcome results

Primary

Number of Subjects With a Cardiopulmonary Event

The number of any cardiopulmonary event, not limited to: Cardiac arrest Sustained ventricular tachycardia (VT) Hypotension requiring inotropes or intra-aortic balloon pump (IABP) insertion Intubation or mechanical ventilation Complete heart block Bradycardia requiring insertion of a pacing wire or external pacing, and Percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG)

Time frame: Within 72 hours of presentation to ED

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EnrolledNumber of Subjects With a Cardiopulmonary Event145 Participants
Secondary

Cumulative Number of Cardiopulmonary Events in a Single Subject

The cumulative number of any cardiac and cardiac-related events, not limited to: In-hospital Death In-hospital Cardiac Arrest Composite cardiovascular outcome or intervention (Lethal Arrhythmias , Acute Pulmonary Edema, Cardiogenic Shock, Myocardial Infarction, Percutaneous Coronary Intervention, Coronary artery Bypass Surgery , New or Recurrent MI, Recurrent Ischemia requiring Revascularization)

Time frame: Within 72 hours of presentation to ED

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026